Evidence map›Paper›PMID 39661866›Full record

ArticleOrganic letters2024

Photocatalyst for Visible-Light-Driven Sm(II)-Mediated Reductions.

Monika Tomar, Caroline Bosch, Jules Everaert, Rohan Bhimpuria, Anders Thapper, Andreas Orthaber, K Eszter Borbas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Organic letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Photodriven Sm-Catalyzed Asymmetric Ketyl-Olefin Coupling.Journal of the American Chemical Society · 2026
    Article
  2. Photochemical strategies in divalent samarium catalysis.Beilstein journal of organic chemistry · 2026
    Review
  3. Contemporary Strategies in SmIAngewandte Chemie (International ed. in English) · 2025
    Review
  4. SmIAngewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Monika TomarDepartment of Chemistry, Ångström Laboratory, Uppsala University, Box 523, 75120 Uppsala, Sweden.
Caroline BoschDepartment of Chemistry, Ångström Laboratory, Uppsala University, Box 523, 75120 Uppsala, Sweden.
Jules EveraertDepartment of Chemistry, Ångström Laboratory, Uppsala University, Box 523, 75120 Uppsala, Sweden.
Rohan BhimpuriaDepartment of Chemistry, Ångström Laboratory, Uppsala University, Box 523, 75120 Uppsala, Sweden.ORCID 0009-0001-5326-9922
Anders ThapperDepartment of Chemistry, Ångström Laboratory, Uppsala University, Box 523, 75120 Uppsala, Sweden.ORCID 0000-0001-7643-302X
Andreas OrthaberDepartment of Chemistry, Ångström Laboratory, Uppsala University, Box 523, 75120 Uppsala, Sweden.ORCID 0000-0001-5403-9902
K Eszter BorbasDepartment of Chemistry, Ångström Laboratory, Uppsala University, Box 523, 75120 Uppsala, Sweden.ORCID 0000-0003-2449-102X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Commercially available coumarin 343 in combination with reducible Sm(III) ions catalyzed divalent lanthanide-mediated C═O, C-halogen, P-Cl, and N═N reductions at ambient temperature in aqueous solvent mixtures. The catalyst absorbs visible light efficiently. The active divalent species is formed by photoinduced electron transfer from coumarin 343 to the stable trivalent precursor, and the coumarin could be regenerated by strictly 1 equiv of ascorbic acid.

Identifiers

PMID39661866
PMCPMC11667727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.